Publication | Open Access

Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen

Late RiskBreast OncologyEarly Breast CancerMedicineGynecologyBreast CancerMenopauseMenopause Hormone TherapyOncologyRadiation OncologyEndocrine-related CancerWomen's HealthPostmenopausal Women